COGNARA HEALTH
Know the Risk Before It Becomes Harm.
Legal and bioethical assessment and health data risk analysis for healthcare organisations, research institutions, and policymakers.
+ Grounded in rigorous methodology.
+ Built for the decisions that affect real people.
THE CHALLENGE
Where Health Risk Hides.
What standard review processes often miss
Healthcare and life sciences organisations are handling more sensitive data, running more complex research, and deploying more new technology than ever before — genomic data, clinical records, AI-driven diagnostics, and large-scale research datasets all carry risks that conventional review processes were never designed to catch. Ethics committees move fast and data protection checklists are built for generic compliance, not for the specific risks of health information and the people behind it. The result is a gap between what is formally reviewed and what is actually at risk.
The Oversight Gap
Risk changes as data moves between systems, is shared with partners, repurposed for new research, or retained longer than originally intended. Most reviews capture a single moment, not the full lifecycle.
Data Sensitivity
Standard data protection reviews are not built for the realities of health information — data that can identify someone, their family, and their future risk profile, sometimes irreversibly. Genetic, clinical, and behavioural health data each carry distinct risk profiles that generic frameworks flatten into one.
Ethical Complexity
A checklist cannot tell you whether a consent process genuinely respects autonomy, or whether a research design quietly disadvantages a vulnerable group. These are judgement calls that need structured, independent reasoning — not a tick-box form.
Independence
Internal ethics and governance processes are valuable, but they are not always independent of institutional pressure to proceed. An external, structured assessment gives decision-makers a view that has not been shaped by the outcome they are hoping for.
OUR OUTPUT
A Complete Risk and Ethics Picture, Built for Your Decision.
Bioethics Assessment Reports
A structured, independent evaluation of the ethical dimensions of a research project, clinical programme, or health technology initiative — covering consent, autonomy, fairness, and impact on participants or patients.
Health Data Risk Reports
A clear assessment of how health data is collected, stored, shared, and used, identifying where vulnerabilities sit and what could realistically go wrong — and why.
Governance Frameworks
Practical frameworks and recommendations that help organisations strengthen oversight of health data and research ethics on an ongoing basis, not just for a single review.
Ethics Opinions
Independent opinions to support research ethics committees and institutional review processes, giving decision-makers a documented, defensible basis for difficult calls.
Lifecycle Risk Mapping
A view of how risk evolves as health data moves through its lifecycle — from collection through to sharing, secondary use, and retention.
WHO WE WORK WITH
Built for Every Organisation Handling Health Data or Conducting Health Research.
Healthcare Providers
You are introducing a new system, partnership, or data-sharing arrangement and need to understand the risk before committing. Our assessment gives you an independent view of where exposure sits, so decisions are made with full visibility rather than after the fact.
Health Technology Companies
You are building a product that touches health data — diagnostics, monitoring, genomics, or AI-driven decision support — and need to understand the ethical and risk implications before they become regulatory or reputational problems. We help you see them early.
Research Institutions and Universities
Your research ethics committee is reviewing a study involving health, genetic, or behavioural data and wants a second, independent opinion on the ethical and data risk dimensions. We provide a structured assessment that supports rigorous, defensible review.
Policymakers and Public Bodies
You are shaping guidance or frameworks for health data governance and need an independent, evidence-based view of where current approaches fall short. Our assessments provide a rigorous basis for policy decisions.
SCOPE OF ASSESSMENT
Covering the Full Range of Health Data and Research Contexts.
Genetic and Genomic Data
Risk assessment for the collection, storage, and use of genetic data, recognising its unique sensitivity and the long-term implications of its disclosure or misuse.
Research and Trial Data
Bioethics and risk assessment for clinical trials, observational studies, and research programmes involving human participants.
Clinical and Patient Data
Assessment of how patient records and clinical data are protected and used across healthcare delivery, research, and technology partnerships.
Health Technology and AI
Assessment of the ethical and data risk implications of AI-driven diagnostics, monitoring tools, and other emerging health technologies.